{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:59:15Z","timestamp":1769849955105,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T00:00:00Z","timestamp":1700956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T00:00:00Z","timestamp":1700956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10928-023-09895-3","type":"journal-article","created":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T18:01:31Z","timestamp":1701021691000},"page":"199-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Semi-mechanistic modeling of resistance development to \u03b2-lactam and \u03b2-lactamase-inhibitor combinations"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9255-2456","authenticated-orcid":false,"given":"Sebastian T.","family":"Tandar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda B.S.","family":"Aulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M. J.","family":"Leemkuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Liakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G. Coen","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,26]]},"reference":[{"key":"9895_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nurpra.2014.10.008","volume":"11","author":"CM Oliphant","year":"2015","unstructured":"Oliphant CM, Eroschenko K (2015) Antibiotic resistance, Part 2: gram-negative pathogens. JNP-J Nurse Pract 11:79\u201386","journal-title":"JNP-J Nurse Pract"},{"key":"9895_CR2","first-page":"625170","volume":"2012","author":"RH Dhillon","year":"2012","unstructured":"Dhillon RH, Clark J (2012) ESBLs: a clear and present danger? Crit Care Res Pract 2012:625170","journal-title":"Crit Care Res Pract"},{"issue":"1","key":"9895_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/CMR.00037-09","volume":"23","author":"SM Drawz","year":"2010","unstructured":"Drawz SM, Bonomo RA (2010) Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 23(1):160\u2013201. https:\/\/doi.org\/10.1128\/CMR.00037-09","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"9895_CR4","doi-asserted-by":"publisher","first-page":"e01906","DOI":"10.1128\/AAC.01906-18","volume":"63","author":"H Abodakpi","year":"2019","unstructured":"Abodakpi H, Chang KT, Gao S, S\u00e1nchez-D\u00edaz AM, Cant\u00f3n R, Tam VH (2019) Optimal piperacillin-tazobactam dosing strategies against extended-Spectrum-\u03b2-Lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 63(2):e01906\u2013e01918. https:\/\/doi.org\/10.1128\/AAC.01906-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9895_CR5","doi-asserted-by":"publisher","first-page":"105885","DOI":"10.1016\/j.ijantimicag.2020.105885","volume":"55","author":"K Abdelraouf","year":"2020","unstructured":"Abdelraouf K, Chavda KD, Satlin MJ, Jenkins SG, Kreiswirth BN, Nicolau DP (2020) Piperacillin-tazobactam-resistant\/third-generation cephalosporin-susceptible Escherichia coli and Klebsiella pneumoniae isolates: resistance mechanisms and in vitro-in vivo discordance. Int J Antimicrob Agents 55(3):105885","journal-title":"Int J Antimicrob Agents"},{"key":"9895_CR6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fmicb.2019.00833","volume":"10","author":"K Zhou","year":"2019","unstructured":"Zhou K, Tao Y, Han L, Ni Y, Sun J (2019) Piperacillin-Tazobactam (TZP) resistance in Escherichia coli due to hyperproduction of TEM-1 \u03b2-Lactamase mediated by the promoter Pa\/Pb. Front Microbiol 10:833. https:\/\/doi.org\/10.3389\/fmicb.2019.00833","journal-title":"Front Microbiol"},{"key":"9895_CR7","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3389\/fmicb.2018.01422","volume":"9","author":"MH Nicolas-Chanoine","year":"2018","unstructured":"Nicolas-Chanoine MH, Mayer N, Guyot K, Dumont E, Pag\u00e8s JM (2018) Interplay between membrane permeability and enzymatic barrier leads to antibiotic-dependent resistance in Klebsiella Pneumoniae. Front Microbiol 9:1422. https:\/\/doi.org\/10.3389\/fmicb.2018.01422","journal-title":"Front Microbiol"},{"issue":"4","key":"9895_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/CMR.00043-12","volume":"25","author":"L Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez L, Hancock RE (2012) Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev 25(4):661\u2013681. https:\/\/doi.org\/10.1128\/CMR.00043-12","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"9895_CR9","doi-asserted-by":"publisher","first-page":"e4817","DOI":"10.1371\/journal.pone.0004817","volume":"4","author":"JM Pages","year":"2009","unstructured":"Pages JM, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, Noussair L, Nicolas-Chanoine MH (2009) Efflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS ONE 4(3):e4817. https:\/\/doi.org\/10.1371\/journal.pone.0004817","journal-title":"PLoS ONE"},{"issue":"4","key":"9895_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/antibiotics10040415","volume":"10","author":"L Kakoullis","year":"2021","unstructured":"Kakoullis L, Papachristodoulou E, Chra P, Panos G (2021) Mechanisms of antibiotic resistance in important gram-positive and gram-negative pathogens and novel antibiotic solutions. Antibiot (Basel Switzerland) 10(4):415. https:\/\/doi.org\/10.3390\/antibiotics10040415","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"1","key":"9895_CR11","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1038\/s41598-019-38943-7","volume":"9","author":"E Heinz","year":"2019","unstructured":"Heinz E, Ejaz H, Bartholdson Scott J, Wang N, Gujaran S, Pickard D, Wilksch J, Cao H, Haq IU, Dougan G, Strugnell RA (2019) Resistance mechanisms and population structure of highly drug resistant Klebsiella in Pakistan during the introduction of the carbapenemase NDM-1. Sci Rep 9(1):2392. https:\/\/doi.org\/10.1038\/s41598-019-38943-7","journal-title":"Sci Rep"},{"key":"9895_CR12","doi-asserted-by":"publisher","first-page":"17001","DOI":"10.1038\/nmicrobiol.2017.1","volume":"2","author":"M Masi","year":"2017","unstructured":"Masi M, R\u00e9fregiers M, Pos KM, Pag\u00e8s JM (2017) Mechanisms of envelope permeability and antibiotic influx and efflux in gram-negative bacteria. Nat Microbiol 2:17001. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.1","journal-title":"Nat Microbiol"},{"issue":"3","key":"9895_CR13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/acs.analchem.8b03586","volume":"91","author":"H Prochnow","year":"2019","unstructured":"Prochnow H, Fetz V, Hotop SK, Garc\u00eda-Rivera MA, Heumann A, Br\u00f6nstrup M (2019) Subcellular quantification of uptake in gram-negative bacteria. Anal Chem 91(3):1863\u20131872. https:\/\/doi.org\/10.1021\/acs.analchem.8b03586","journal-title":"Anal Chem"},{"issue":"2","key":"9895_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/pharmaceutics14020246","volume":"14","author":"K Mi","year":"2022","unstructured":"Mi K, Zhou K, Sun L, Hou Y, Ma W, Xu X, Huo M, Liu Z, Huang L (2022) Application of semi-mechanistic pharmacokinetic and pharmacodynamic model in antimicrobial resistance. Pharmaceutics 14(2):246. https:\/\/doi.org\/10.3390\/pharmaceutics14020246","journal-title":"Pharmaceutics"},{"issue":"3","key":"9895_CR15","doi-asserted-by":"publisher","first-page":"zcab027","DOI":"10.1093\/narcan\/zcab027","volume":"3","author":"S Sahoo","year":"2021","unstructured":"Sahoo S, Mishra A, Kaur H, Hari K, Muralidharan S, Mandal S, Jolly MK (2021) A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER + Breast cancer cells. NAR cancer 3(3):zcab027. https:\/\/doi.org\/10.1093\/narcan\/zcab027","journal-title":"NAR cancer"},{"issue":"7","key":"9895_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1099\/jmm.0.000768","volume":"67","author":"A Liakopoulos","year":"2018","unstructured":"Liakopoulos A, Betts J, La Ragione R, van Essen-Zandbergen A, Ceccarelli D, Petinaki E, Koutinas CK, Mevius DJ (2018) Occurrence and characterization of extended-spectrum cephalosporin-resistant enterobacteriaceae in healthy household dogs in Greece. J. Med. Microbiol 67(7):931\u2013935","journal-title":"J. Med. Microbiol"},{"issue":"28","key":"9895_CR17","doi-asserted-by":"publisher","first-page":"E2629","DOI":"10.1073\/pnas.1310333110","volume":"110","author":"S Kojima","year":"2013","unstructured":"Kojima S, Nikaido H (2013) Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels. PNAS 110(28):E2629\u2013E2634","journal-title":"PNAS"},{"issue":"5","key":"9895_CR18","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1128\/AAC.01714-09","volume":"54","author":"SP Lim","year":"2010","unstructured":"Lim SP, Nikaido H (2010) Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob Agents Chemother 54(5):1800\u20131806. https:\/\/doi.org\/10.1128\/AAC.01714-09","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9895_CR19","doi-asserted-by":"publisher","first-page":"e56926","DOI":"10.1371\/journal.pone.0056926","volume":"8","author":"M Faheem","year":"2013","unstructured":"Faheem M, Rehman MT, Danishuddin M, Khan AU (2013) Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-\u03b2-lactam-\u03b2-lactamase inhibitor. PLoS ONE 8(2):e56926. https:\/\/doi.org\/10.1371\/journal.pone.0056926","journal-title":"PLoS ONE"},{"issue":"52","key":"9895_CR20","doi-asserted-by":"publisher","first-page":"52724","DOI":"10.1074\/jbc.M306059200","volume":"278","author":"MS Helfand","year":"2003","unstructured":"Helfand MS, Bethel CR, Hujer AM, Hujer KM, Anderson VE, Bonomo RA (2003) Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130. J Biol Chem 278(52):52724\u201352729. https:\/\/doi.org\/10.1074\/jbc.M306059200","journal-title":"J Biol Chem"},{"issue":"2","key":"9895_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF01923511","volume":"48","author":"MR Maurizi","year":"1992","unstructured":"Maurizi MR (1992) Proteases and protein degradation in Escherichia coli. Experientia 48(2):178\u2013201. https:\/\/doi.org\/10.1007\/BF01923511","journal-title":"Experientia"},{"issue":"1","key":"9895_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14756369909030337","volume":"15","author":"M Perilli","year":"2000","unstructured":"Perilli M, Franceschini N, Bonfiglio G, Segatore B, Stefani S, Nicoletti G, Perez MM, Bianchi C, Zollo A, Amicosante G (2000) A kinetic study on the interaction between tazobactam (a penicillanic acid sulphone derivative) and active-site serine beta-lactamases. J Enzyme Inhib 15(1):1\u201310. https:\/\/doi.org\/10.1080\/14756369909030337","journal-title":"J Enzyme Inhib"},{"issue":"3","key":"9895_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/pr.111.005769","volume":"65","author":"EI Nielsen","year":"2013","unstructured":"Nielsen EI, Friberg LE (2013) Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs. Pharmacol Rev 65(3):1053\u20131090. https:\/\/doi.org\/10.1124\/pr.111.005769","journal-title":"Pharmacol Rev"},{"issue":"8","key":"9895_CR24","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1128\/AAC.46.8.2327-2332.2002","volume":"46","author":"E Viane","year":"2002","unstructured":"Viane E, Chanteux H, Servais H, Mingeot-Leclercq M-P, Tulkens PM (2002) Comparative Stability Studies of antipseudomonal-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrob Agents Chemoter 46(8):2327\u20132332. https:\/\/doi.org\/10.1128\/AAC.46.8.2327-2332.2002","journal-title":"Antimicrob Agents Chemoter"},{"issue":"5","key":"9895_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1302\/2046-3758.65.BJR-2017-0276.R1","volume":"6","author":"E Samara","year":"2017","unstructured":"Samara E, Moriarty TF, Decosterd LA, Richards RG, Gautier E, Wahl P (2017) Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cement. Bone Jt Res 6(5):296\u2013306. https:\/\/doi.org\/10.1302\/2046-3758.65.BJR-2017-0276.R1","journal-title":"Bone Jt Res"},{"issue":"10","key":"9895_CR26","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1128\/AAC.00285-06","volume":"50","author":"FM Kaczmarek","year":"2006","unstructured":"Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD (2006) High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35\/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 50(10):3396\u20133406. https:\/\/doi.org\/10.1128\/AAC.00285-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9895_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/microorganisms9020271","volume":"9","author":"YJ Lee","year":"2021","unstructured":"Lee YJ, Huang CH, Ilsan NA, Lee IH, Huang TW (2021) Molecular epidemiology and characterization of carbapenem-resistant Klebsiella pneumoniae isolated from urine at a teaching hospital in Taiwan. Microorganisms 9(2):271. https:\/\/doi.org\/10.3390\/microorganisms9020271","journal-title":"Microorganisms"},{"issue":"1","key":"9895_CR28","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1038\/s41598-019-40279-1","volume":"9","author":"T Singh","year":"2019","unstructured":"Singh T, Singh PK, Das S, Wani S, Jawed A, Dar SA (2019) Transcriptome analysis of beta-lactamase genes in diarrheagenic Escherichia coli. Sci Rep 9(1):3626. https:\/\/doi.org\/10.1038\/s41598-019-40279-1","journal-title":"Sci Rep"},{"issue":"10","key":"9895_CR29","doi-asserted-by":"publisher","first-page":"e01202","DOI":"10.1128\/AAC.01202-18","volume":"62","author":"AK Jones","year":"2018","unstructured":"Jones AK, Ranjitkar S, Lopez S, Li C, Blais J, Reck F, Dean CR (2018) Impact of Inducible blaDHA-1 on susceptibility of Klebsiella pneumoniae clinical isolates to LYS228 and identification of chromosomal mpl and ampD mutations mediating Upregulation of plasmid-borne blaDHA-1 expression. Antimicrob Agents Chemother 62(10):e01202\u2013e01218. https:\/\/doi.org\/10.1128\/AAC.01202-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"9895_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0022-2836(02)00400-X","volume":"320","author":"X Wang","year":"2002","unstructured":"Wang X, Minasov G, Shoichet BK (2002) Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J Mol Biol 320(1):85\u201395. https:\/\/doi.org\/10.1016\/S0022-2836(02)00400-X","journal-title":"J Mol Biol"},{"issue":"Pt 7","key":"9895_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1099\/jmm.0.030577-0","volume":"60","author":"N Ramdani-Bouguessa","year":"2011","unstructured":"Ramdani-Bouguessa N, Manageiro V, Jones-Dias D, Ferreira E, Tazir M, Cani\u00e7a M (2011) Role of SHV \u03b2-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to \u03b2-lactams in an Algerian hospital. J Med Microbiol 60(Pt 7):983\u2013987. https:\/\/doi.org\/10.1099\/jmm.0.030577-0","journal-title":"J Med Microbiol"},{"issue":"4","key":"9895_CR32","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1128\/AAC.01275-10","volume":"55","author":"YK Tsai","year":"2011","unstructured":"Tsai YK, Fung CP, Lin JC, Chen JH, Chang FY, Chen TL, Siu LK (2011) Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55(4):1485\u20131493. https:\/\/doi.org\/10.1128\/AAC.01275-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"9895_CR33","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1089\/mdr.2018.0414","volume":"25","author":"N Maurya","year":"2019","unstructured":"Maurya N, Jangra M, Tambat R, Nandanwar H (2019) Alliance of efflux pumps with \u03b2-lactamases in multidrug-resistant Klebsiella pneumoniae isolates. Microb Drug Resist 25(8):1155\u20131163. https:\/\/doi.org\/10.1089\/mdr.2018.0414","journal-title":"Microb Drug Resist"},{"issue":"2","key":"9895_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1208\/s12248-009-9112-5","volume":"11","author":"M Bergstrand","year":"2009","unstructured":"Bergstrand M, Karlsson MO (2009) Handling data below the limit of quantification in mixed effect models. AAPS J 11(2):371\u2013380. https:\/\/doi.org\/10.1208\/s12248-009-9112-5","journal-title":"AAPS J"},{"key":"9895_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.phrs.2015.06.002","volume":"99","author":"LE Clegg","year":"2015","unstructured":"Clegg LE, Mac Gabhann F (2015) Molecular mechanism matters: benefits of mechanistic computational models for drug development. Pharmacol Res 99:149\u2013154. https:\/\/doi.org\/10.1016\/j.phrs.2015.06.002","journal-title":"Pharmacol Res"},{"issue":"2\u20133","key":"9895_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0378-1097(91)90089-s","volume":"63","author":"KA Graeme-Cook","year":"1991","unstructured":"Graeme-Cook KA (1991) The regulation of porin expression in Escherichia coli: effect of turgor stress. FEMS Microbiol Lett 63(2\u20133):219\u2013223. https:\/\/doi.org\/10.1016\/0378-1097(91)90089-s","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"9895_CR37","doi-asserted-by":"publisher","first-page":"e00095","DOI":"10.1128\/mSphere.00095-18","volume":"3","author":"M Zhu","year":"2018","unstructured":"Zhu M, Dai X (2018) High salt cross-protects Escherichia coli from antibiotic treatment through increasing efflux pump expression. mSphere 3(2):e00095\u2013e00018. https:\/\/doi.org\/10.1128\/mSphere.00095-18","journal-title":"mSphere"},{"issue":"6","key":"9895_CR38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/microorganisms8060833","volume":"8","author":"A Ferrand","year":"2020","unstructured":"Ferrand A, Vergalli J, Pag\u00e8s JM, Davin-Regli A (2020) An intertwined network of regulation controls membrane permeability including drug influx and efflux in enterobacteriaceae. Microorganisms 8(6):833. https:\/\/doi.org\/10.3390\/microorganisms8060833","journal-title":"Microorganisms"},{"key":"9895_CR39","doi-asserted-by":"publisher","first-page":"712007","DOI":"10.3389\/fmicb.2021.712007","volume":"12","author":"F Wong","year":"2021","unstructured":"Wong F, Wilson S, Helbig R, Hegde S, Aftenieva O, Zheng H, Liu C, Pilizota T, Garner EC, Amir A, Renner LD (2021) Understanding beta-lactam-induced lysis at the single-cell level. Front Microbiol 12:712007. https:\/\/doi.org\/10.3389\/fmicb.2021.712007","journal-title":"Front Microbiol"},{"issue":"5","key":"9895_CR40","doi-asserted-by":"publisher","first-page":"e0251594","DOI":"10.1371\/journal.pone.0251594","volume":"16","author":"SM Khalifa","year":"2021","unstructured":"Khalifa SM, El-Aziz A, Hassan AM, Abdelmegeed ES (2021) \u03b2-lactam resistance associated with \u03b2-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae. PLoS ONE 16(5):e0251594. https:\/\/doi.org\/10.1371\/journal.pone.0251594","journal-title":"PLoS ONE"},{"issue":"2","key":"9895_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jac\/48.2.259","volume":"48","author":"MK Kim","year":"2001","unstructured":"Kim MK, Xuan D, Quintiliani R, Nightingale CH, Nicolau DP (2001) Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam. J Antimicrob Chemother 48(2):259\u2013267. https:\/\/doi.org\/10.1093\/jac\/48.2.259","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"9895_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11538-021-00982-5","volume":"84","author":"A Sher","year":"2022","unstructured":"Sher A, Niederer SA, Mirams GR, Kirpichnikova A, Allen R, Pathmanathan P, Gavaghan DJ, van der Graaf PH, Noble D (2022) A quantitative systems pharmacology perspective on the importance of parameter identifiability. Bull Math Biol 84(3):39. https:\/\/doi.org\/10.1007\/s11538-021-00982-5","journal-title":"Bull Math Biol"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-023-09895-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-023-09895-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-023-09895-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T16:21:18Z","timestamp":1716999678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-023-09895-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,26]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["9895"],"URL":"https:\/\/doi.org\/10.1007\/s10928-023-09895-3","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,26]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}